Depression is a common psychiatric disorder and one of the leading causes of disability worldwide. Antidepressants are the first-line treatment for moderate to severe major depressive episodes. Despite their effectiveness, only 40% of patients respond to the first antidepressant they try. A recent paper in Nature Communication strongly suggests that a particular protein, GPR56, is involved in the biology of depression and the effect of antidepressants.
Les tentatives de suicide ne sont pas toutes pareilles. Ce n’est pas un phénomène homogène ou unique. "Les gens font des tentatives dans des contextes différents, avec des intentions différentes," précise d’entrée de jeu le psychiatre Gustavo Turecki, qui est aussi directeur du Groupe McGill d’études sur le suicide et directeur du Réseau québécois sur le suicide, les troubles de l’humeur et troubles associés.
Category:
Published on: 31 Jan 2018
Category:
Published on: 2 Jan 2015
Category:
Published on: 5 Sep 2014
By Cynthia Lee - News - June 8, 2014
Levels of a small molecule found only in humans and in other primates are lower in the brains of depressed individuals, according to researchers at McGill University and the Douglas Institute. This discovery may hold a key to improving treatment options for those who suffer from depression.
Category:
Published on: 8 Jun 2014
